Vaxart, Inc.
NASDAQ:VXRTBiotechnology
Healthcare
$0.53 -1.75%
-$0.01 today
- Market cap
- $129.30M
- Beta
- 1.09
- P/E (TTM)
- 3.6
- EPS (TTM)
- $0.15
52W Low $0.26High $0.84
Volume 0.12M
Average 0.41M
Price history
Vaxart, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+40.58%
Period high
$0.80
Period low
$0.35
Latest
$0.53
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| DFAN14A | Jul 2, 2026 | Jul 2, 2026 | |
| 8-K | Jul 2, 2026 | Jul 2, 2026 | |
| DEFA14A | Jul 2, 2026 | Jul 2, 2026 | |
| DEFA14A | Jul 1, 2026 | Jul 1, 2026 | |
| 8-K | Jun 26, 2026 | Jun 26, 2026 | |
| DEFA14A | Jun 26, 2026 | Jun 26, 2026 | |
| DEFA14A | Jun 26, 2026 | Jun 26, 2026 | |
| DEFA14A | Jun 26, 2026 | Jun 26, 2026 | |
| DEFA14A | Jun 26, 2026 | Jun 26, 2026 | |
| DFAN14A | Jun 22, 2026 | Jun 22, 2026 | |
| DEFA14A | Jun 16, 2026 | Jun 16, 2026 | |
| DEFA14A | Jun 16, 2026 | Jun 16, 2026 | |
| DFAN14A | Jun 9, 2026 | Jun 9, 2026 | |
| DFAN14A | Jun 8, 2026 | Jun 8, 2026 | |
| DEFA14A | Jun 8, 2026 | Jun 8, 2026 |
Competitors
Who does Vaxart, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about VXRT's filings, answered from its disclosures.
What is the latest VXRT filing?
The latest filing shown is DEFA14A dated Jul 2, 2026.
How many recent filings does VXRT have?
Intrinsic Alpha currently shows 20 recent filings for VXRT.
Continue the stock analysis
Jump to another research area for this company.